This 2021 observational study from the International Journal of Environmental Research and Public Health (PMID: 33925359) examined gut microbiota composition, intestinal permeability, diet, and cytokine levels in Brazilian patients with relapsing-remitting multiple sclerosis (RRMS) on disease-modifying therapies. Compared to healthy controls, RRMS patients showed gut dysbiosis with increased Akkermansia muciniphila
